A novel in vitro method for detecting undifferentiated human pluripotent stem cells as impurities in cell therapy products using a highly efficient culture system

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Tano, Keiko ^a,b   Yasuda, Satoshi ^b   Kuroda, Takuya ^b   Saito, Hirohisa ^a   Umezawa, Akihiro ^a   Sato, Yoji ^b,c,d,e  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^c NAGOYA CITY UNIVERSITY   (Japan)

^d OSAKA UNIVERSITY   (Japan)

^e KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ASSAY; CELL CULTURE; CELL DENSITY; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; CULTURE MEDIUM; CULTURE TECHNIQUE; EMBRYO; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; MALE; MESENCHYMAL STEM CELL; MOUSE; NERVE CELL; NONHUMAN; PLURIPOTENT STEM CELL; RESIDUE ANALYSIS; STEM CELL EXPANSION; STEM CELL TRANSPLANTATION; ANIMAL; BIOLOGICAL THERAPY; CELL LINE; CHEMISTRY; CYTOLOGY;

CULTURE MEDIUM; LAMININ;

ANIMALS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELL- AND TISSUE-BASED THERAPY; CULTURE MEDIA; HUMANS; IN VITRO TECHNIQUES; INDUCED PLURIPOTENT STEM CELLS; LAMININ; MICE; PLURIPOTENT STEM CELLS;

EID: 84908584397     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110496     Document Type: Article

References (19)

1. Bailey AM (2012) Balancing tissue and tumor formation in regenerative medicine. Sci Transl Med 4: 147fs28. Rev.
2. Kuroda T, Yasuda S, Sato Y (2013) Tumorigenicity studies for human pluripotent stem cell-derived products. Biol. Pharm. Bull 36: 189-192.
3. Kuroda T, Yasuda S, Kusakawa S, Hirata N, Kanda Y, et al. (2012) Highly sensitive in vitro methods for detection of residual undifferentiated cells in retinal pigment epithelial cells derived from human iPS cells. PLoS One 7: e37342.
4. Food and Drug Administration (2008) Cellular Therapies derived from Human Embryonic Stem Cells-Considerations for Pre-Clinical Safety Testing and Patient Monitoring-April 2008. Cellular, Tissue, and Gene Therapies Advisory Committee (CTGTAC) Meeting #45. Available: .
5. Hentze H, Soong PL, Wang ST, Phillips BW, Putti TC, et al. (2009) Teratoma formation by human embryonic stem cells: evaluation of essential parameters for future safety studies. Stem Cell Res 2: 198-210.
6. Watanabe K, Ueno M, Kamiya D, Nishiyama A, Matsumura M, et al. (2007) A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat. Biotechnol 25: 681-686.
7. Rodin S, Antonsson L, Niaudet C, Simonson OE, Salmela E, et al. (2014) Clonal culturing of human embryonic stem cells on laminin-521/E-cadherin matrix in defined and xeno-free environment. Nat. Commun 5: 3195.
8. Miyazaki T, Futaki S, Suemori H, Taniguchi Y, Yamada M, et al. (2012) Laminin E8 fragments support efficient adhesion and expansion of dissociated human pluripotent stem cells. Nat. Commun 3: 1236.
9. Chen G, Gulbranson DR, Hou Z, Bolin JM, Ruotti V, et al. (2011) Chemically defined conditions for human iPSC derivation and culture. Nat. Methods 8: 424-429.
10. Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M, et al. (2009) Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol 27: 275-280.
11. Kajiwara M, Aoi T, Okita K, Takahashi R, Inoue H, et al. (2012) Donordependent variations in hepatic differentiation from human-induced pluripotent stem cells. Proc Natl Acad Sci U S A 109: 12538-12543.
12. Jung Y, Bauer G, Nolta JA (2012) Concise review: Induced pluripotent stem cell-derived mesenchymal stem cells: progress toward safe clinical products. Stem Cells 30: 42-47.
13. Chen YS, Pelekanos RA, Ellis RL, Horne R, Wolvetang EJ, et al. (2012) Small molecule mesengenic induction of human induced pluripotent stem cells to generate mesenchymal stem/stromal cells. Stem Cells Transl Med 1: 83-95.
14. Kimbrel EA, Kouris NA, Yavanian G, Chu J, Qin Y, et al. (2014) Mesenchymal stem cell population derived from human pluripotent stem cells displays potent immunomodulatory and therapeutic properties. Stem Cells Dev 23: 1611-1624.
15. Kanemura H, Go MJ, Nishishita N, Sakai N, Kamao H, et al. (2013) Pigment epithelium-derived factor secreted from retinal pigment epithelium facilitates apoptotic cell death of iPSC. Sci Rep 3: 2334.
16. Xu Y, Zhu X, Hahm HS, Wei W, Hao E, et al. (2010) Revealing a core signaling regulatory mechanism for pluripotent stem cell survival and self-renewal by small molecules. Proc Natl Acad Sci U S A 107: 8129-8134.
17. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, et al. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872.
18. Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, et al. (2008) Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol 26: 101-106.
19. Okita K, Matsumura Y, Sato Y, Okada A, Morizane A, et al. (2011) A more efficient method to generate integration-free human iPS cells. Nat. Methods 8: 409-412.